共 5 条
- [1] Antiretroviral therapy for HIV infection in 1997 - Updated recommendations of the International AIDS Society USA panel[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (24): : 1962 - 1969Carpenter, CCJFischl, MAHammer, SMHirsch, MSJacobsen, DMKatzenstein, DAMontaner, JSGRichman, DDSaag, MSSchooley, RTThompson, MAVella, SYeni, PGVolberding, PA
- [2] Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene[J]. SCIENCE, 1996, 273 (5283) : 1856 - 1862Dean, MCarrington, MWinkler, CHuttley, GASmith, MWAllikmets, RGoedert, JJBuchbinder, SPVittinghoff, EGomperts, EDonfield, SVlahov, DKaslow, RSaah, ARinaldo, CDetels, ROBrien, SJ
- [3] TREATMENT WITH LAMIVUDINE, ZIDOVUDINE, OR BOTH IN HIV-POSITIVE PATIENTS WITH 200 TO 500 CD4+ CELLS PER CUBIC MILLIMETER[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (25) : 1662 - 1669ERON, JJBENOIT, SLJEMSEK, JMACARTHUR, RDSANTANA, JQUINN, JBKURITZKES, DRFALLON, MARUBIN, M
- [4] A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) : 725 - 733Hammer, SMSquires, KEHughes, MDGrimes, JMDemeter, LMCurrier, JSEron, JJFeinberg, JEBalfour, HHDayton, LRChodakewitz, JAFischl, MA
- [5] The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) : 1091 - 1098Katzenstein, DAHammer, SMHughes, MDGundacker, HJackson, JBFiscus, SRasheed, SElbeik, TReichman, RJapour, AMerigan, TCHirsch, MS